These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 12518062)

  • 1. Nitric oxide-induced cellular stress and p53 activation in chronic inflammation.
    Hofseth LJ; Saito S; Hussain SP; Espey MG; Miranda KM; Araki Y; Jhappan C; Higashimoto Y; He P; Linke SP; Quezado MM; Zurer I; Rotter V; Wink DA; Appella E; Harris CC
    Proc Natl Acad Sci U S A; 2003 Jan; 100(1):143-8. PubMed ID: 12518062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide and p53 in cancer-prone chronic inflammation and oxyradical overload disease.
    Goodman JE; Hofseth LJ; Hussain SP; Harris CC
    Environ Mol Mutagen; 2004; 44(1):3-9. PubMed ID: 15199542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proinflammatory cytokine-induced cellular senescence of biliary epithelial cells is mediated via oxidative stress and activation of ATM pathway: a culture study.
    Sasaki M; Ikeda H; Sato Y; Nakanuma Y
    Free Radic Res; 2008 Jul; 42(7):625-32. PubMed ID: 18608517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the IRF-1 tumour modifier during the response to genotoxic stress involves an ATM-dependent signalling pathway.
    Pamment J; Ramsay E; Kelleher M; Dornan D; Ball KL
    Oncogene; 2002 Nov; 21(51):7776-85. PubMed ID: 12420214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arecoline-induced phosphorylated p53 and p21(WAF1) protein expression is dependent on ATM/ATR and phosphatidylinositol-3-kinase in clone-9 cells.
    Chou WW; Guh JY; Tsai JF; Hwang CC; Chiou SJ; Chuang LY
    J Cell Biochem; 2009 Jun; 107(3):408-17. PubMed ID: 19343784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase.
    Vaziri H; West MD; Allsopp RC; Davison TS; Wu YS; Arrowsmith CH; Poirier GG; Benchimol S
    EMBO J; 1997 Oct; 16(19):6018-33. PubMed ID: 9312059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced phosphorylation of p53 serine 18 following DNA damage in DNA-dependent protein kinase catalytic subunit-deficient cells.
    Araki R; Fukumura R; Fujimori A; Taya Y; Shiloh Y; Kurimasa A; Burma S; Li GC; Chen DJ; Sato K; Hoki Y; Tatsumi K; Abe M
    Cancer Res; 1999 Aug; 59(15):3543-6. PubMed ID: 10446957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer chemoprevention by the antioxidant tempol acts partially via the p53 tumor suppressor.
    Erker L; Schubert R; Yakushiji H; Barlow C; Larson D; Mitchell JB; Wynshaw-Boris A
    Hum Mol Genet; 2005 Jun; 14(12):1699-708. PubMed ID: 15888486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The negative role of cyclin G in ATM-dependent p53 activation.
    Ohtsuka T; Jensen MR; Kim HG; Kim KT; Lee SW
    Oncogene; 2004 Jul; 23(31):5405-8. PubMed ID: 15077171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin and p53 act on different pathways to induce G1 arrest in mammalian cells.
    Metcalfe SM; Canman CE; Milner J; Morris RE; Goldman S; Kastan MB
    Oncogene; 1997 Oct; 15(14):1635-42. PubMed ID: 9349496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic interactions between atm and p53 influence cellular proliferation and irradiation-induced cell cycle checkpoints.
    Westphal CH; Schmaltz C; Rowan S; Elson A; Fisher DE; Leder P
    Cancer Res; 1997 May; 57(9):1664-7. PubMed ID: 9135004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenite induces p53 accumulation through an ATM-dependent pathway in human fibroblasts.
    Yih LH; Lee TC
    Cancer Res; 2000 Nov; 60(22):6346-52. PubMed ID: 11103796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATM/ATR and SMAD3 pathways contribute to 3-indole-induced G₁ arrest in cancer cells and xenograft models.
    Huang SM; Lu KT; Wang YC
    Anticancer Res; 2011 Jan; 31(1):203-8. PubMed ID: 21273599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide, a mediator of inflammation, suppresses tumorigenesis.
    Hussain SP; Trivers GE; Hofseth LJ; He P; Shaikh I; Mechanic LE; Doja S; Jiang W; Subleski J; Shorts L; Haines D; Laubach VE; Wiltrout RH; Djurickovic D; Harris CC
    Cancer Res; 2004 Oct; 64(19):6849-53. PubMed ID: 15466171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ataxia telangiectasia-mutated and p53 are potential mediators of chloroquine-induced resistance to mammary carcinogenesis.
    Loehberg CR; Thompson T; Kastan MB; Maclean KH; Edwards DG; Kittrell FS; Medina D; Conneely OM; O'Malley BW
    Cancer Res; 2007 Dec; 67(24):12026-33. PubMed ID: 18089834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA-dependent protein kinase is not required for accumulation of p53 or cell cycle arrest after DNA damage.
    Rathmell WK; Kaufmann WK; Hurt JC; Byrd LL; Chu G
    Cancer Res; 1997 Jan; 57(1):68-74. PubMed ID: 8988043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nature of G1/S cell cycle checkpoint defect in ataxia-telangiectasia.
    Khanna KK; Beamish H; Yan J; Hobson K; Williams R; Dunn I; Lavin MF
    Oncogene; 1995 Aug; 11(4):609-18. PubMed ID: 7651723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ataxia-telangiectasia mutated is not required for p53 induction and apoptosis in irradiated epithelial tissues.
    Gurley KE; Kemp CJ
    Mol Cancer Res; 2007 Dec; 5(12):1312-8. PubMed ID: 18171989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The isoflavonoids genistein and quercetin activate different stress signaling pathways as shown by analysis of site-specific phosphorylation of ATM, p53 and histone H2AX.
    Ye R; Goodarzi AA; Kurz EU; Saito S; Higashimoto Y; Lavin MF; Appella E; Anderson CW; Lees-Miller SP
    DNA Repair (Amst); 2004 Mar; 3(3):235-44. PubMed ID: 15177039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ataxia telangiectasia mutated and p21CIP1 modulate cell survival of drug-induced senescent tumor cells: implications for chemotherapy.
    Crescenzi E; Palumbo G; de Boer J; Brady HJ
    Clin Cancer Res; 2008 Mar; 14(6):1877-87. PubMed ID: 18347191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.